Navigation Links
Cancer risk among nuclear industry workers

A cohort multinational study was done involving 598 068 nuclear industry workers from 15 countries.// The study was done to estimate the risk of cancer after administrating low doses of radiation.

This study is an international collaborative study to estimate the cancer risk among radiation workers in the nuclear industry to find out the risk of cancer occurrence after low dose exposure of radiation.

The study recruits were employed in 154 different facilities, involved in nuclear power production, research, waste management and industries of fuel, isotope and weapon. During the study period, about 24,158 (5.9%) of recruits died, 6519 from cancer other than leukaemia and 196 from leukaemia (excluding lymphocytic leukaemia).

Results from the study show that there is an increased risk of cancer exists in the recruits even at a low dose and a significant increase risk for all cancers (excluding leukaemia). Some factors like smoking and diet in recruits can have an association between radiation dose and risk of cancer. Some earlier studies have found associations between radiation dose and smoking and while others have not. Factors such as smoking can confound the association between radiation doses and risk only if they are related both to risk of cancer and to dose.

Current recommendations form the International Commission on Radiological Protection (ICRP) are to limit occupational doses to 100 Sv (sieverts) over five years (not to exceed 50 Sv in any one year) and doses to the public to 1 Sv per year. This study results show that an exposure of 100 Sv will cause 9.7% mortality from cancer (excluding leukaemia), and a 5.9% increased mortality from cancers excluding leukaemia, lung, and pleura.

Our study is the largest study on nuclear industry workers conducted so far, and provides an estimation of radiation risk. These results suggest that there is an increased risk of cancer occurs even at a lower dose of nucle ar radiation.


Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:

(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, officials of ... Narconon network, announced the release of a new cutting edge recovery program that has ... been working with drug- and alcohol-addicted individuals with the purpose to free addicts from ...
(Date:11/25/2015)... ... , ... Smiles by Stevens is pleased to announce the addition ... many patients are aware of the benefits of Botox® in the treatment of moderate ... with discomfort, soreness, and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) ...
(Date:11/25/2015)... ... , ... In an ongoing Clinical Study conducted by an independent physician, Andrew ... is evaluating the efficacy of its product and its disinfection protocol. This study is ... May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in ...
(Date:11/25/2015)... Silver Spring, Md (PRWEB) , ... November 25, ... ... the Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups ... the history of this disease. The Periwinkle Pioneers, nominated by the public, will ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , 26 november 2015 ... kondigt de geplande investering aan van ten ... de laboratoria en het mondiale hoofdkantoor in ... uitbreiding zal resulteren in extra kantoorruimte en ... aan de groeiende behoeften van de farmaceutische ...
(Date:11/26/2015)... -- --> --> Juntendo ... optimal contrast weighting of MRI for patients with Multiple ... research agreement with SyntheticMR in order to use SyMRI in ... possible to generate multiple contrast images from a single scan ... thus making it possible to both fine tune images and ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 ... the addition of the "2016 Future Horizons ... Monitoring (TDM) Market: Supplier Shares, Country Segment Forecasts, ... offering. --> ... comprehensive analysis of the Japanese therapeutic drug monitoring ...
Breaking Medicine Technology: